Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010

IMPORTANCE: Postmarket safety events of novel pharmaceuticals and biologics occur when new safety risks are identified after initial regulatory approval of these therapeutics. These safety events can change how novel therapeutics are used in clinical practice and inform patient and clinician decisio...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:JAMA
Egile Nagusiak: Downing, Nicholas S., Shah, Nilay D., Aminawung, Jenerius A., Pease, Alison M., Zeitoun, Jean-David, Krumholz, Harlan M., Ross, Joseph S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Medical Association 2017
Gaiak:
Original Investigation
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5815036/
https://ncbi.nlm.nih.gov/pubmed/28492899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2017.5150
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak